InvestorsHub Logo
Post# of 312701
Next 10
Followers 381
Posts 15030
Boards Moderated 2
Alias Born 05/23/2009

Re: None

Sunday, 09/20/2020 9:31:09 PM

Sunday, September 20, 2020 9:31:09 PM

Post# of 312701
$ITOX UNBELIEVABLE AT THIS PRICE THE CALVARY IS COMING
$ITOX .0129. 52 week high over 2,000% higher at 26 cents. ITOX could be my next 1,000%+ alert. Like my alert on PNNX from 0035 - 89 cents, HENC 0017- 47 cents, HMLA 0017 to 9 cents ALPP 006- 40 cents, SHMP 0068 to 98 cents all within the last 18 months. ALL THESE STOCKS WERE UNKNOWN. All overlooked even as I pointed extensive, elaborate DD, months later as they went viral people using what I pointed out MONTHS prior to push them.???????

ITOX is one such 10,000% plus percentage running GEM. I have so much to write about it but I'll keep this short and simple so as not to bore you.

This MICROSCOPIC float artificial intelligence tech company is UNKNOWN and the current environment of stay at home etc that comes with Coronavirus is perfect for ITOX in more ways than one. Not only due to its technology will be useful to create new methods of conferencing, etc but also to find a cure. A new consortium of top scientists will be able to use some of the world’s most advanced supercomputers to look for solutions.

CEO FORMER VICE PRESIDENT OF R&D for MEDTRONIC which trades at $99!! Just ran over 700% to .0229 from my alert at 0035 in 2 days, will break 3 cents on the next run. 2 million on the bid! Look at the management. These guys are big boys, brains in the artificial intelligence arena. All connections with M.I.T and Medtronic. Wont be down here for long. 52 week high 26 cents!!???????????

Some VERY interesting stuff;

“Year over Year (“YoY”) revenue growth for the nine months ended September 30, 2019, was 29.6% below the same period last year. These results are at the lower side of our YTD revenue goals, and due to a lag in capital raised to date, we expect our 2019 annual revenue growth to fall below our previously anticipated levels. Due to this shortfall in capital funds, we expect both final quarter and annual 2019 revenues to be flat versus 2018 levels. On a positive note, during the first three quarters of 2019, additional customers entered Non-Disclosure Agreements (“NDAs”), a critical first step in the customer development process. This quarter we signed an NDA with an additional potential customer, bringing the total number of potential new customers with NDAs to six: two Medical Device companies (one of which is a Fortune 500 company); one Pharma company (another Fortune 500 company); one Aerospace (also a Fortune 500 company); one Automotive (a multinational corporation, based in Europe); and a multinational infrastructure company based in Asia. Although we are pleased with the number of new customers under NDA, we expect fewer customers will place their first orders in 2019 than previously anticipated. This is due to delays in bringing on full time sales staff, caused by the shortfall in anticipated capital raise. Despite these headwinds, our confidence is buoyed by factors stated previously: The continuing impact of an experienced leadership team; execution from our technology team, especially in the area of Artificial Intelligence & Machine Learning (“AI & ML”); execution of contracts secured; and focus on high potential growth markets (specifically Biotech, Pharma, and Medical Device Operations). Furthermore, we expect our business will continue to benefit from the rapid growth of the Industrial Internet of Things (“IIoT”) market, and our unique value proposition to serve said rapidly growing market. Market research shows the worldwide IIoT market in 2017 was $92 billion USD and is projected to be $227 billion USD by 2021 (25% CAGR). Our edge computing open-source hardware and proprietary ML algorithms employ our minimally-invasive load monitoring (“MILM”) technology to simply gather data and gain insights to monitor & scope power, move from preventive to predictive maintenance, and even optimize development and manufacturing processes. This unique value proposition has been embraced by our customers, including a Fortune 500 Pharmaceutical Manufacturer. It is important to repeat that our year to date results were at the lower end of our revenue goals due to the lag in securing additional capital funding, which totaled $160,000 in Q3 of 2019 ($35,000 more than reported last quarter).

While 2019 YoY revenue is expected to be flat compared to 2018, we remain optimistic for 2020 revenue growth. This is due to the factors stated above that are now firmly in place: experienced leadership; savvy technological talent, operational execution excellence; and focus on new customers and expanded business with the current customer base. Combined with the continued rapid growth of the IIoT market and the anticipated continued infusion of additional capital funding, we believe that we remain on track for strong growth and performance in 2020.”

ITOX is here sitting at 0126 their Convertible notes are all 1000%+ higher than current price!

$ITOX: Guess what Tom Siebel is involved in ???????

Same space as $ITOX

Keep an eye on this.............

https://c3.ai/

ITOX CEO is a wizard do your due diligence on this guy and you'll see what I'm taking about. The whole management are brains.

https://www.linkedin.com/in/cliff-emmons

ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX ITOX

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.